Choong Ang Vaccine Laboratory Co., Ltd. (072020.KQ)
- Previous Close
10,700.00 - Open
10,700.00 - Bid 10,700.00 x --
- Ask 10,710.00 x --
- Day's Range
10,650.00 - 10,740.00 - 52 Week Range
9,960.00 - 15,400.00 - Volume
36,648 - Avg. Volume
46,231 - Market Cap (intraday)
103.348B - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 12, 2024 - Aug 16, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Choong Ang Vaccine Laboratory Co., Ltd., operates as an animal vaccine company, primarily engages in the production and sale of pharmaceutical products that promote animal health and welfare in Korea. Its vaccine products include SuiShot, PoulShot, CaniShot, BoviShot, FeliShot, RabbiShot, and AquaShot for preventing diseases and infection in pigs, poultry, dogs, cattle, cats, rabbits, and fish. The company was founded in 1968 and is based in Daejeon, South Korea.
www.cavac.co.kr167
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 072020.KQ
Performance Overview: 072020.KQ
Trailing total returns as of 6/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 072020.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 072020.KQ
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
8.54%
Return on Assets (ttm)
1.78%
Return on Equity (ttm)
3.53%
Revenue (ttm)
36.93B
Net Income Avi to Common (ttm)
3.15B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
18.14B
Total Debt/Equity (mrq)
11.60%
Levered Free Cash Flow (ttm)
-12.07B